术前免疫营养对膀胱切除术后围手术期结局的影响
该单中心回顾性研究纳入204例因膀胱癌行根治性膀胱切除术的患者,比较接受口服L-精氨酸基术前免疫营养补充(pre-INS)与未接受者的围手术期结局。结果显示pre-INS与术后感染和全肠外营养(TPN)需求显著降低相关,多变量分析中pre-INS是术后感染的显著预测因素。
要点
- 术前免疫营养与术后感染风险降低显著相关(25% vs 45%,OR=0.41)。
- 术前免疫营养与术后TPN需求降低显著相关(17.3% vs 35.6%,OR=0.38)。
- 多变量分析中pre-INS仅对术后感染有显著预测作用,对其他结局无显著影响。
核心结论
- 基于L-精氨酸的术前免疫营养补充与根治性膀胱切除术后感染显著减少相关。
研究设计与样本
- 单中心回顾性综述,纳入204例因膀胱癌行根治性膀胱切除术的患者,比较接受与未接受口服L-精氨酸基pre-INS者。
主要发现
- pre-INS组术后TPN需求为17.3%,未接受组为35.6%(Fisher p=0.015,OR=0.38)。
- pre-INS组术后感染发生率为25%,未接受组为45%(Fisher p=0.003,OR=0.41)。
- 其他结局(高级别并发症、再入院、肠梗阻、LOS)在两组间无显著差异。
- 多变量logistic回归调整年龄、性别、BMI、Charlson合并症指数、新辅助化疗和手术特征后,pre-INS是术后感染的显著预测因素(Fisher p=0.02;OR=0.35),但对高级别并发症、再入院、肠梗阻、TPN需求或LOS无显著预测作用。
临床怎么用
- 对于拟行根治性膀胱切除术的膀胱癌患者,可考虑术前使用基于L-精氨酸的免疫营养补充以降低术后感染风险。
局限性
- 本研究为单中心回顾性设计,可能存在选择偏倚和混杂因素。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Radical cystectomy (RC) for the management of muscle-invasive bladder cancer remains a morbid procedure with high rates of perioperative complications. The role of preoperative immunonutritional supplementation (pre-INS) in improving post-RC outcomes is promising and needs further validation. MATERIALS AND METHODS: We performed a retrospective review of 204 patients who underwent RC for bladder cancer at a single institution, comparing patients who received oral L-arginine-based pre-INS, and those who did not. Preoperative features, postoperative complications, and readmission data were collected. Outcomes of interest included development of high-grade (Clavien-Dindo III-V) complications, readmission within 30 days, ileus, total parenteral nutrition (TPN) requirement, postoperative infection, and length of stay (LOS). Categorical and continuous outcomes were assessed using Fisher's exact test and Welch T-test, respectively. Multivariable logistic regression (MLoR) analysis was used to identify predictive factors for our outcomes. RESULTS: Patients who received pre-INS had significantly lower odds of requiring postoperative TPN (17.3% vs 35.6%; Fisher p=0.015, OR=0.38) and developing postoperative infection (25% vs 45%; Fisher p=0.003; OR=0.41) but no significant difference in the rates of other outcomes. On MLoR, when adjusting for age, gender, body mass index, Charlson comorbidity index, undergoing neoadjuvant chemotherapy and operative features, pre-INS was a significant predictor of postoperative infection (Fisher p=0.02; OR=0.35) but not for high-grade complications, readmission, ileus, needing TPN or LOS. CONCLUSIONS: Preoperative immunonutrition with an L-arginine-based supplement is associated with significant reduction in postoperative infection, one of the most common complications of RC.
引用
- Khaleel S, Regmi S, Hannah P, et al. Impact of Preoperative Immunonutrition on Perioperative Outcomes following Cystectomy. J Urol. 2021. PMID: 34184927. doi:10.1097/JU.0000000000001945
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。